| Kyle Alden Menzel, MD | |
|
Community Memorial Hospital, 512 Skyline Boulevard, Cloquet, MN 55720-1199 | |
| (218) 879-4641 | |
| Not Available |
| Full Name | Kyle Alden Menzel |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 27 Years |
| Location | Community Memorial Hospital, Cloquet, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780650317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 40774-020 (Wisconsin) | Secondary |
| 207X00000X | Orthopaedic Surgery | 53101 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Memorial Hospital | Cloquet, MN | Hospital |
| Cook Hospital | Cook, MN | Hospital |
| St Lukes Hospital | Duluth, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Memorial Hospital Association | 0042129991 | 25 |
News Archive
In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks. Known as either cancer initiating cells (CICs) or leukemia initiating cells (LICs), these stealth populations are impervious to conventional chemotherapy and undaunted by targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that bear responsibility for the disease's reemergence.
New research suggests that fainting may be genetic and, in some families, only one gene may be responsible. However, a predisposition to certain triggers, such as emotional distress or the sight of blood, may not be inherited.
Implants that obtain their energy from blood sugar and oxygen: Dr. Sven Kerzenmacher at the Department of Microsystems Engineering (IMTEK) of the University of Freiburg is researching the development of biological fuel cells with the goal of finding an inexhaustible source of power in the human body. He has been awarded the 2011 FAM Research Prize for his dissertation by the Forum for Applied Microsystems Technology (FAM).
More than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women to breast cancer, Yale scientists have pinpointed the molecular mechanism that allows those mutations to wreak their havoc.
› Verified 1 days ago
| Entity Name | Community Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003869082 PECOS PAC ID: 0042129991 Enrollment ID: O20040202001203 |
News Archive
In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks. Known as either cancer initiating cells (CICs) or leukemia initiating cells (LICs), these stealth populations are impervious to conventional chemotherapy and undaunted by targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that bear responsibility for the disease's reemergence.
New research suggests that fainting may be genetic and, in some families, only one gene may be responsible. However, a predisposition to certain triggers, such as emotional distress or the sight of blood, may not be inherited.
Implants that obtain their energy from blood sugar and oxygen: Dr. Sven Kerzenmacher at the Department of Microsystems Engineering (IMTEK) of the University of Freiburg is researching the development of biological fuel cells with the goal of finding an inexhaustible source of power in the human body. He has been awarded the 2011 FAM Research Prize for his dissertation by the Forum for Applied Microsystems Technology (FAM).
More than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women to breast cancer, Yale scientists have pinpointed the molecular mechanism that allows those mutations to wreak their havoc.
› Verified 1 days ago
| Entity Name | Northern Itasca Hospital District |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1851335525 PECOS PAC ID: 3274442173 Enrollment ID: O20060505000928 |
News Archive
In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks. Known as either cancer initiating cells (CICs) or leukemia initiating cells (LICs), these stealth populations are impervious to conventional chemotherapy and undaunted by targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that bear responsibility for the disease's reemergence.
New research suggests that fainting may be genetic and, in some families, only one gene may be responsible. However, a predisposition to certain triggers, such as emotional distress or the sight of blood, may not be inherited.
Implants that obtain their energy from blood sugar and oxygen: Dr. Sven Kerzenmacher at the Department of Microsystems Engineering (IMTEK) of the University of Freiburg is researching the development of biological fuel cells with the goal of finding an inexhaustible source of power in the human body. He has been awarded the 2011 FAM Research Prize for his dissertation by the Forum for Applied Microsystems Technology (FAM).
More than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women to breast cancer, Yale scientists have pinpointed the molecular mechanism that allows those mutations to wreak their havoc.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Alden Menzel, MD Community Memorial Hospital, 512 Skyline Boulevard, Cloquet, MN 55720-1199 Ph: (218) 879-4641 | Kyle Alden Menzel, MD Community Memorial Hospital, 512 Skyline Boulevard, Cloquet, MN 55720-1199 Ph: (218) 879-4641 |
News Archive
In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks. Known as either cancer initiating cells (CICs) or leukemia initiating cells (LICs), these stealth populations are impervious to conventional chemotherapy and undaunted by targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that bear responsibility for the disease's reemergence.
New research suggests that fainting may be genetic and, in some families, only one gene may be responsible. However, a predisposition to certain triggers, such as emotional distress or the sight of blood, may not be inherited.
Implants that obtain their energy from blood sugar and oxygen: Dr. Sven Kerzenmacher at the Department of Microsystems Engineering (IMTEK) of the University of Freiburg is researching the development of biological fuel cells with the goal of finding an inexhaustible source of power in the human body. He has been awarded the 2011 FAM Research Prize for his dissertation by the Forum for Applied Microsystems Technology (FAM).
More than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women to breast cancer, Yale scientists have pinpointed the molecular mechanism that allows those mutations to wreak their havoc.
› Verified 1 days ago
Timothy L. Mcleod, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 512 Skyline Blvd, Cloquet, MN 55720 Phone: 218-878-7645 | |
Joseph Frederick Lemker, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 512 Skyline Blvd, Cloquet, MN 55720 Phone: 218-879-4641 Fax: 218-879-9167 |